TechNavio’s analysts forecast the Global Medical Biosensors market to grow at a CAGR of 9.4 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increased sales of glucose monitoring devices. The Global Medical Biosensors market has also been witnessing increase in investments by vendors on technological developments. However, poor durability of biological enzymes applied in biosensors could pose a challenge to the growth of this market.

TechNavio’s report, the Global Medical Biosensors Market 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Biosensors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Abbott Laboratories, LifeScan Inc., Hoffmann-La Roche Ltd., and Bayer Healthcare AG.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?